68ga-bbn-irdye800cw
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02910804)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-bbn-irdye800cw
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03407781 | Early Phase 1 (Phase 1) | Jan 1, 2016 | Capital Medical University, Chinese Academy of Medical Sciences, National Institutes of Health (NIH) |
| NCT02910804 | Early Phase 1 (Phase 1) | Nov 1, 2015 | Capital Medical University, Chinese Academy of Medical Sciences, National Institutes of Health (NIH), Tsinghua University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 2 | 1 | 2015 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2015 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 1 | 2015 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1